Find Articles



Return to:Diabetes Articles
Or:Recent Diabetes Articles

Arpida Reports Progress in Pivotal Phase III Trial With TLT Treatment ...


http://www.forbes.com/prnewswire/feeds/prnewswire/2008/01...

Forbes - It is one of the most common dermatological diseases, affecting an estimated 30 million people in the USA alone while prevalence is steadily increasing for various reasons, e.g. the aging of the population, diabetes etc. Oral therapies that are ...



Article Finder:

January 22, 2008 12:15:00 AM
Article Directory